...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: BETonMACE Placebo Estimate

torpedoman - I think you have two different falls from glory wrapped in one. I was a shareholder during both episodes. The fall from $30 went down to about $11 as the stop losses got taken out and then closed the day at, I think $17ish. That was in 2007 or 2008. I was a relatively new shareholder at that time and had just a few shares so wasn't to concerned. The fall to $ .15 in June of 2013 came from a share price closing around $3.60 the day before. Yes the 10 million shares that traded that day was huge given that there was less than 50 million shares outstanding at the time. My understanding is that Zenith was spun off in May 2013 so that we would have all that IP to follow up on after RVX got bought out in the following couple of months. Obviously RVX did not get takin out and now we have 2 companies with BET drugs, one focusing on oncology and one that seems to focus on everything else in the world.

If I have left any blanks empty I think Rocketman2 can fill them in.

tada

Share
New Message
Please login to post a reply